Apoptosis in the pathogenesis of systemic lupus erythematosus.

Abstract:

:Systemic lupus erythematosus (SLE) is a prototype inflammatory autoimmune disease resulting from autoimmune responses against nuclear autoantigens. During apoptosis many lupus autoantigens congregate inside the cells and are susceptible to modifications. Modified nuclear constituents are considered foreign and dangerous. Therefore, apoptotic cells have to has to be efficiently removed to avoid the accumulation of apoptotic debris and the subsequently development of autoimmune responses. Hence, apoptosis and clearance of apoptotic cells/material are considered key processes in the aetiology of SLE. Clearance deficiencies may account for the development of autoimmunity by inducing a loss of tolerance in lymphoid tissues. Furthermore, phagocytosis of apoptotic cells may lead to a pro-inflammatory response in the presence of autoantibodies. This may sustain inflammatory conditions and the pathology found in overt lupus.

journal_name

Lupus

journal_title

Lupus

authors

Munoz LE,van Bavel C,Franz S,Berden J,Herrmann M,van der Vlag J

doi

10.1177/0961203308089990

subject

Has Abstract

pub_date

2008-05-01 00:00:00

pages

371-5

issue

5

eissn

0961-2033

issn

1477-0962

pii

17/5/371

journal_volume

17

pub_type

杂志文章,评审

相关文献

LUPUS文献大全
  • Improving the prognosis of SLE without prescribing lupus drugs and the primary care paradox.

    abstract::The outcome, quality of life and prognosis of lupus patients can be enhanced with close follow up and coordination between the individual's primary care physician and rheumatologist. Rheumatologists usually do not act as primary care physicians and leave health care maintenance to practitioners who need to be reminded...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307086267

    authors: Wallace DJ

    更新日期:2008-02-01 00:00:00

  • The African Lupus Genetics Network (ALUGEN) registry: standardized, prospective follow-up studies in African patients with systemic lupus erythematosus.

    abstract:BACKGROUND:The prevalence and severity of systemic lupus erythematosus (SLE) differs between ethnic groups and geographical regions. Although initially reported as rare, there is growing evidence that SLE is prevalent and runs a severe course in Africa. There is a paucity of prospective studies on African SLE patients....

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203315606984

    authors: Hodkinson B,Mapiye D,Jayne D,Kalla A,Tiffin N,Okpechi I

    更新日期:2016-03-01 00:00:00

  • Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritis.

    abstract::Several studies have investigated the potential of various autoantibody tests in the diagnosis of systemic lupus erythematosus (SLE). Many lupus patients initially present with glomerulonephritis. In that clinical situation the main differential diagnosis are other forms of glomerulonephritis. In this study the diagno...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309345753

    authors: Heidenreich U,Mayer G,Herold M,Klotz W,Stempfl Al-Jazrawi K,Lhotta K

    更新日期:2009-12-01 00:00:00

  • Antibodies against phospholipids other than cardiolipin: potential roles for both phospholipid and protein.

    abstract::Autoantibodies to phospholipids other than cardiolipin have received less attention, to date, than anti-cardiolipin antibodies. This review focuses on these antibodies and potential roles for both phospholipid and protein in their reactivity. We review data in the literature indicating that antibodies to phosphatidyle...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339600500534

    authors: Rauch J,Janoff AS

    更新日期:1996-10-01 00:00:00

  • Sinus node disfunction in an adolescent with systemic lupus erythematosus.

    abstract::Cardiac involvement in systemic lupus erythematosus (SLE) is well documented. The pericardium, myocardium and endocardium, as well as the coronary arteries, the valves and the conduction system can all be affected. While pericarditis is common, arrythmias are less frequently described.We present a 13-year-old male, wh...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320974091

    authors: Fogaça da Mata M,Rebelo M,Sousa HS,Rocha A,Miguel P,Oliveira Ramos F,Costa-Reis P

    更新日期:2020-11-20 00:00:00

  • Genetic selection pressure in TLR9 gene may enforce risk for SLE in Indian Tamils.

    abstract::Objectives Lupus is a classical systemic autoimmune disease with genetics as one of the well known causative factors for the disease pathogenesis. Toll-like receptors are the major pattern recognition receptors associated with innate immunity and also act as an interface with the adaptive immunity. Genetic polymorphis...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316659151

    authors: Yusuf JH,Kaliyaperumal D,Jayaraman M,Ramanathan G,Devaraju P

    更新日期:2017-03-01 00:00:00

  • Autoantibodies to topoisomerase I in a patient with systemic lupus erythematosus without features of scleroderma.

    abstract::We report a woman with systemic lupus erythematosus (SLE) with diffuse proliferative glomerulonephritis and anti-dsDNA antibodies whose serum contained autoantibodies specific for the phosphorylated form of RNA polymerase II (RNAP IIO), Su and ribosomal P antigen, as well as anti-topoisomerase I antibodies, a marker f...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339500400414

    authors: Stojanov L,Satoh M,Dooley MA,Kuwana M,Jennette JC,Reeves WH

    更新日期:1995-08-01 00:00:00

  • Increased levels of circulating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjögren's syndrome.

    abstract::High levels of serum and/or plasma circulating DNA (cDNA) have been described in patients with systemic autoimmune diseases (SADs). However, the role of this molecule has not been clarified. Our aim was to evaluate plasma cDNA levels in 48 systemic lupus erythematosus (SLE) and 44 primary Sjögren's syndrome (SS) patie...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311399606

    authors: Bartoloni E,Ludovini V,Alunno A,Pistola L,Bistoni O,Crinò L,Gerli R

    更新日期:2011-08-01 00:00:00

  • Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real-time RT-PCR.

    abstract::HIN200 is a human IFN-inducible gene and homologous to murine IFI202 gene, which was identified as a candidate gene for SLE susceptibility in lupus mouse model. We determined these gene expressions in leukocytes from 20 SLE patients and 10 healthy controls and in renal biopsies from 29 SLE patients and 15 kidney donor...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309106699

    authors: Kimkong I,Avihingsanon Y,Hirankarn N

    更新日期:2009-10-01 00:00:00

  • A North American perspective of content and quality of websites in the English language on childhood-onset lupus erythematosus.

    abstract::Objective The objective of this article is to examine the quality, content, and readability of information and resources in the English language and accessible on the internet by pediatric patients with systemic lupus erythematosus (SLE) and their families in North America. Methods Keywords relevant to SLE were genera...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317746246

    authors: Cutler C,Peng T,Stinson J,Tucker L,Boneparth A,Klein Gitelman M,Moorthy LN

    更新日期:2018-04-01 00:00:00

  • Cat scratch disease (bartonellosis) mimicking an SLE flare.

    abstract::Only recently Bartonella species have been recognized as important human pathogens. Cat scratch disease (CSD), caused by infection with Bartonella henselae, shows a steady increase in the number of cases throughout the world. We report a case of an 18-year-old woman with systemic lupus erythematosus (SLE) who presente...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120301701548373

    authors: Gaubitz M,Herrmann M,Shahin M,Schotte H,Willeke P,Domschke W

    更新日期:2001-01-01 00:00:00

  • IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.

    abstract:OBJECTIVE:To determine whether the intrathecal concentrations of cytokines/chemokines are associated with, or influenced by, serum concentrations in patients with central neuropsychiatric systemic lupus erythematosus (NPSLE), and to ascertain whether the increased production of cytokines/chemokines intrathecally relati...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316629556

    authors: Yoshio T,Okamoto H,Kurasawa K,Dei Y,Hirohata S,Minota S

    更新日期:2016-08-01 00:00:00

  • A clinical and serological comparison of familial and non-familial systemic lupus erythematosus in Ireland.

    abstract::Seventeen families, in which the diagnosis of SLE could be verified in two relatives, were included in the study. The diagnosis was made according to the revised 1982 ARA criteria. We compared the 34 cases of familial SLE in these 17 families with 34 non-familial SLE controls matched for age, sex, ethnicity and durati...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339600500408

    authors: Gourley IS,Cunnane G,Bresnihan B,FitzGerald O,Bell AL

    更新日期:1996-08-01 00:00:00

  • Correlation of asymptomatic hyperuricaemia and serum uric acid levels with arterial stiffness in women with systemic lupus erythematosus without clinically evident atherosclerotic cardiovascular disease.

    abstract::The objective of this article was to evaluate whether serum uric acid (SUA) correlates with arterial stiffness and inflammation markers in a cohort of women with systemic lupus erythematosus (SLE) without overt atherosclerotic cardiovascular diseases, who attended a community hospital. One hundred and two women with S...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309355301

    authors: Sabio JM,Vargas-Hitos JA,Mediavilla JD,Navarrete-Navarrete N,Zamora-Posadas M,Pérez-Vicente S,Hidalgo-Tenorio C,Díaz-Chamorro A,Jáimez L,Jiménez-Alonso J,Grupo Lupus Virgen de las Nieves.

    更新日期:2010-04-01 00:00:00

  • Innate immunity and atherogenesis.

    abstract::Atherosclerosis is recognized as the pathological basis of cardiovascular disease (CVD) and recent advances in basic science have shown that it should be considered as a chronic inflammatory process. Both elements of the innate and the adaptive immunity appear to be actively involved in atherogenesis. In fact, the pot...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203305lu2213oa

    authors: Rattazzi M,Faggin E,Bertipaglia B,Pauletto P

    更新日期:2005-01-01 00:00:00

  • The dual role of innate immunity in antiphospholipid syndrome and systemic lupus erythematosus.

    abstract::Antiphospholipid syndrome (APS), as a primary disease or a secondary syndrome in systemic lupus erythematosus (SLE), is characterized by the presence of antiphospholipid antibodies (aPL) and a clinical event. It is likely that both genetic and environmental factors lead to the development of aPL and progression to dis...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314548248

    authors: Salem D,Subang R,Laplante P,Levine JS,Rauch J

    更新日期:2014-10-01 00:00:00

  • Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.

    abstract::C4d deposition in peritubular capillaries (PTC) has been used as a marker of antibody-mediated rejection (AMR). However, PTC C4d deposition is not described in patients with lupus nephritis (LN). C4d deposition in PTC was detected in 455 patients with biopsy proven LN in the present study. Renal tissues from 21 cases ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307083279

    authors: Li SJ,Liu ZH,Zen CH,Wang QW,Wang Y,Li LS

    更新日期:2007-01-01 00:00:00

  • High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome.

    abstract::Abnormalities of the lipid profile partly explain the atherogenic tendency of systemic lupus erythematosus but the picture is unclear in thrombotic primary antiphospholipid syndrome (PAPS). Herein we compare the lipid profile, high-density lipoprotein (HDL), low-density lipoprotein (LDL), total cholesterol (CHO), apol...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309357765

    authors: Ames PR,Matsuura E,Batuca JR,Ciampa A,Lopez LL,Ferrara F,Iannaccone L,Alves JD

    更新日期:2010-05-01 00:00:00

  • Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production.

    abstract::Tumour necrosis factor (TNFalpha) is a cytokine with a wide range of diverse and at times paradoxical effects. These include immunoregulatory, lymphoid organogenesis and pro-inflammatory effects. In recent years, TNFalpha has become a focus of interest more for its inflammatory effects in a number of chronic autoimmun...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203302lu306rr

    authors: Mageed RA,Isenberg DA

    更新日期:2002-01-01 00:00:00

  • A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.

    abstract:OBJECTIVE:To determine if dehydroepiandrosterone (DHEA) is beneficial in severe systemic lupus erythematosus (SLE). METHODS:A double-blinded, placebo-controlled, randomized clinical trial in 21 patients with severe and active SLE, manifestated primarily by nephritis, serositis or hematological abnormalities. In additi...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1191/096120399678847588

    authors: van Vollenhoven RF,Park JL,Genovese MC,West JP,McGuire JL

    更新日期:1999-01-01 00:00:00

  • A case of progressive multifocal leukoencephalopathy in a lupus patient treated with belimumab.

    abstract::Belimumab is a monoclonal antibody against soluble B-lymphocyte stimulator, an essential growth factor for B-cell maturation and activation, which was approved by the US FDA in 2011 for patients with active autoantibody-positive systemic lupus erythematosus (SLE) who have failed standard treatment. Here we present the...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314524292

    authors: Fredericks CA,Kvam KA,Bear J,Crabtree GS,Josephson SA

    更新日期:2014-06-01 00:00:00

  • Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus.

    abstract::Mesenchymal stem cells have been applied to treat graft versus host disease as they have immunosuppressive ability and can overcome the major histocompatibility complex-histocompatibility barrier. The potential of allogeneic mesenchymal stem cells in treating systemic lupus erythematosus (SLE) was investigated in this...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320928419

    authors: Liu F,Chen H,Chen T,Lau CS,Yu FX,Chen K,Chen HP,Pan RS,Chan GC,Zhang XY,Nie YJ

    更新日期:2020-07-01 00:00:00

  • Reactivation of systemic lupus erythematosus in a dialysis patient after tuberculous peritonitis.

    abstract::The disease activity of patients suffering from lupus nephritis usually becomes quiescent after the onset of end stage renal failure. Reactivation of lupus activity, especially after a long period of dialysis, is uncommon. Factors that might trigger off lupus reactivation after dialysis have not been well defined. We ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203302lu096cr

    authors: Lui SL,Lam MF,Tse KC,Lo WK

    更新日期:2002-01-01 00:00:00

  • Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus.

    abstract::Up to 80% of patients with systemic lupus erythematosus (SLE) are treated with nonsteroidal anti-inflammatory drugs (NSAID) for musculoskeletal symptoms, serositis and headache. This survey reviews the literature on non-selective and selective inhibitors of cyclooxygenases, with an emphasis on the efficacy and safety ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120300678828794

    authors: Ostensen M,Villiger PM

    更新日期:2000-01-01 00:00:00

  • Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.

    abstract::Congenital heart block occurs in fetuses of Ro/SSA and La/SSB positive women. To investigate the stability of maternal autoantibody levels during pregnancy, we followed Ro52, Ro60 and La autoantibody IgG level variation and Ro52 subclass profiles longitudinally in selected congenital heart block risk pregnancies. Seru...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203306lu2309oa

    authors: Strandberg L,Salomonsson S,Bremme K,Sonesson S,Wahren-Herlenius M

    更新日期:2006-01-01 00:00:00

  • Uncommon cutaneous manifestations of lupus erythematosus.

    abstract::Cutaneous manifestations of lupus erythematosus (LE) are, usually, characteristic enough to permit an easy diagnosis. However, some patients may present less typical lesions, associated or not to the classic ones. Therefore, irrespectively of the variety of LE (acute, subacute and chronic), in absence of the typical b...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339700600207

    authors: Mascaro JM,Herrero C,Hausmann G

    更新日期:1997-01-01 00:00:00

  • Anti-ganglioside antibodies in patients with systemic lupus erythematosus and neurological manifestations.

    abstract:INTRODUCTION:Anti-ganglioside antibodies (AGA) have been associated with several peripheral neuropathies, such as Miller-Fisher syndrome, Guillain-Barré syndrome and multifocal motor neuropathy. They have also been studied in patients with systemic lupus erythematosus (SLE), focusing on neuropsychiatric manifestations ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312436856

    authors: Labrador-Horrillo M,Martinez-Valle F,Gallardo E,Rojas-Garcia R,Ordi-Ros J,Vilardell M

    更新日期:2012-05-01 00:00:00

  • Atherosclerosis and autoimmunity.

    abstract::Novel risk factors for the progression of atherosclerosis such as C-reactive protein (CRP) and adhesion molecules have stimulated much recent interest in the role of inflammation in atherosclerotic disease. There is also evidence emerging that autoimmunity may have a role in the pathogenesis of atherosclerosis. In thi...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120301680416922

    authors: Gordon PA,George J,Khamashta MA,Harats D,Hughes G,Shoenfeld Y

    更新日期:2001-01-01 00:00:00

  • Prothrombin as cofactor for antiphospholipids.

    abstract::Prothrombin is a common antigenic target of antiphospholipid antibodies, since anti-prothrombin antibodies are detected in about 50-90% of the patients. To allow proper immune recognition, prothrombin must be adsorbed on suitable anionic surfaces. The epitope(s) have not yet been identified: the majority of anti-proth...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339800700209

    authors: Galli M,Barbui T

    更新日期:1998-01-01 00:00:00

  • Pathological manifestation of autoimmune myocarditis is detected prior to glomerulonephritis in a murine model of lupus nephritis.

    abstract:OBJECTIVE:Since enhanced cardiac magnetic resonance imaging (cMRI) signals have been associated with lupus disease activity in humans prior to renal failure and novel, cardiac-focused therapeutic strategies could be investigated with an associated animal model, autoimmune myocarditis was characterized in murine lupus n...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320948959

    authors: Young NA,Jablonski K,Schwarz E,Okafor I,Hampton J,Valiente GR,Henry C,Harb P,Barger J,Bratasz A,Kalyanasundaram A,Ardoin SP,Jarjour WN

    更新日期:2020-11-01 00:00:00